88 results
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
ceases to be Connected for one of the following reasons:
death;
disability, injury or ill health (evidenced to the satisfaction of the Board … 7.5, 7.6, 11 and 13, if the Option Holder ceases to be Connected for any reason (including death);
if the Board shall have exercised its discretion
8-K
EX-10.2
ADAP
Adaptimmune Therapeutics Plc
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
Holder holding a Nominal-Cost Option ceases to be Connected for one of the following reasons:
death;
disability, injury or ill health (evidenced … and 13, if the Option Holder ceases to be Connected for any reason (including death);
if the Board shall have exercised its discretion pursuant to Rule
424B3
ud7 7ozznq2c
20 Apr 23
Prospectus supplement
4:32pm
S-4/A
jyx v1rsu
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
8-K
EX-10.1
fhojed4siz28zb
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
S-4
wfslqnyba21a8ieh
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
424B5
ds9ma0 4ci
28 Apr 22
Prospectus supplement for primary offering
8:09am